Patent · US Active

Nucleolin specific aptamer and use thereof

US8569252B2 · kind B2 · utility

2Cited by
1References
8Claims
0Family size

Assignees

Inventors

Key dates

Filing dateApr 14, 2010
Grant dateOct 29, 2013
Priority date
Expiry dateOct 1, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2310/335
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Improved G-rich oligonucleotide (GRO) aptamers specific to nucleolin, a method of preparing the aptamers, and a use of the aptamers for diagnosing and/or treating a nucleolin-associated disease, are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.